|Articles|September 1, 2006

Pharmacy Times

  • Volume 0
  • 0

Bifantis Effective for Women with IBS

Author(s)Susan Farley

The probiotic (or "good" bacteria) Bifidobacteriuminfantis 35624 (Bifantis) hasproven effective in the management ofirritable bowel syndrome (IBS) in women.The randomized, double-blind, doserangingstudy of 362 women with IBSreceived either a Bifantis capsule orplacebo once a day for 4 weeks. Thepatients, who ranged in age from 18 to65 years, recorded any abdominal pain,bloating, incomplete evacuation, strainingat stool, flatulence, and bowel habitsatisfaction. They also assessed anyrelief of IBS symptoms. After 4 weeks,Bifantis had proved "significantly superiorto placebo" for the relief of abdominalpain, bloating, incomplete evacuation,straining, and flatulence. No significantadverse events were recorded. The studyappeared in the July 2006 issue of theAmerican Journal of Gastroenterology.

Ms. Farley is a freelance medicalwriter based in Wakefield, RI.

Articles in this issue

about 19 years ago

Pharmacy Technology Products

about 19 years ago

Tobacco Use

about 19 years ago

Rx Product News

about 19 years ago

OTC Product News

about 19 years ago

can you READ theseRxs?

about 19 years ago

Generic Times Product News

about 19 years ago

compoundingHOTLINE

about 19 years ago

Compounding for Pediatric Patients

about 19 years ago

Police and Drug Testing

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME